[Cyclophosphamide therapy in multiple sclerosis]. 1990

M Schöffel, and R Zschenderlein, and M Michalik
Abteilung Neurologie, Bereiches Medizin (Charité), Humboldt-Universität zu Berlin.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Schöffel, and R Zschenderlein, and M Michalik
June 2009, Neurology,
M Schöffel, and R Zschenderlein, and M Michalik
February 1972, Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali,
M Schöffel, and R Zschenderlein, and M Michalik
April 1969, Lancet (London, England),
M Schöffel, and R Zschenderlein, and M Michalik
March 2007, Expert opinion on drug safety,
M Schöffel, and R Zschenderlein, and M Michalik
March 1987, Deutsche medizinische Wochenschrift (1946),
M Schöffel, and R Zschenderlein, and M Michalik
January 2007, The Cochrane database of systematic reviews,
M Schöffel, and R Zschenderlein, and M Michalik
January 2002, The Cochrane database of systematic reviews,
M Schöffel, and R Zschenderlein, and M Michalik
January 1993, Rinsho shinkeigaku = Clinical neurology,
M Schöffel, and R Zschenderlein, and M Michalik
August 1987, Archives of neurology,
M Schöffel, and R Zschenderlein, and M Michalik
October 2009, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
Copied contents to your clipboard!